Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine

Author(s):: Pijpers, J.A.; Ferrari, M.D. (0000-0001-9691-9449); Terwindt, G.M.

Published: 2020
Publication type: Article / Letter to editor

Date issued: 2020-01-01
Language: English
Publisher: OXFORD UNIV PRESS
Is part of
hdl: 1887/3182711
doi: 10.1093/brain/awz368
URL: https://academic.oup.com/brain/article/143/1/e6/5647312